MedTrace Logo

Clinical Trial to Evaluate the Model SC9 IOL Compared to the Model LI61SE IOL (Bausch & Lomb)

NCT03179397 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 338

Last updated 2023-08-30

No results posted yet for this study

Summary

To evaluate the Model SC9 Intraocular Lens for the improvement of near and intermediate vision when compared to a legally marketed monofocal IOL.

Conditions

  • Cataract

Interventions

DEVICE

Model SC9

Experimental

DEVICE

Model LI61SE

Active Comparator

Sponsors & Collaborators

  • CORD, LLC

    lead INDUSTRY

Principal Investigators

  • John Hovanesian, M.D. · CORD, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-31
Primary Completion
2021-10-04
Completion
2023-07-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03179397 on ClinicalTrials.gov